Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dosing and hemodynamics during general anesthesia induction in elderly patients
ChiCTR2200060437Phase 4Not yet recruiting
- Sponsor
- Zhoukou Central Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Perioperative cardiovascular instability (PCVI) (4 arms), sponsored by Zhoukou Central Hospital. Primary endpoints: systolic blood pressure, diastolic blood pressure and 1 more. Planned start May 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Perioperative cardiovascular instability (PCVI)
Beyond the preview
Go deeper on ChiCTR2200060437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060437.